Amyotrophic lateral sclerosis (ALS; motor neuron disease) is a relentlessly progressive disorder. After half a century of trials, only one drug with modest disease-modifying potency--riluzole--has been developed. The diagnosis of this disorder is still clinical and there is a pronounced delay between the onset of symptoms and diagnosis, possibly beyond the therapeutic window. Bedside quantification of the involvement of the corticospinal tract and extramotor areas is inadequate and functional...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Biomarkers in amyotrophic lateral sclerosis.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record